Inhibitory glutamatergic feedback for brain tumor therapy
Medical Oncology · 2026
DOI: 10.1007/s12032-025-03212-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Oncology, 2026. Verfasst von Ray X Lee. Beteiligte Einrichtung: Division of Convergence Research, MIT Sigma Xi, Cambridge, MA, USA. raylee@mit.edu. Hauptthemen laut MEDLINE: Brain Neoplasms, Glutamic Acid, Glioma. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Neuronal excitatory activity promotes glioma progression through glutamate-mediated signaling, yet effective ways to counter this using intrinsic brain mechanisms remain undefined. Repeated low-frequency neuronal stimulation can lead to glutamate buildup and pathway-specific activation of inhibitory presynaptic metabotropic glutamate receptors (mGluRs) within neural circuits. This perspective introduces a hypothesis that this mechanism can disrupt tumor-promoting neuron-glioma interactions. This direction introduces a biologically grounded strategy for a distinctive therapeutic path in precision neuro-oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Convergence Research, MIT Sigma Xi, Cambridge, MA, USA. raylee@mit.edu.
- Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA. raylee@mit.edu.
- Program in Media Arts and Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA. raylee@mit.edu.
Zitieren
APA
Lee, R. X. (2026). Inhibitory glutamatergic feedback for brain tumor therapy. Medical Oncology. https://doi.org/10.1007/s12032-025-03212-3
Vancouver
Lee RX. Inhibitory glutamatergic feedback for brain tumor therapy. Medical Oncology. 2026. doi:10.1007/s12032-025-03212-3
BibTeX
@article{Lee2026,
author = {Lee, Ray X},
title = {Inhibitory glutamatergic feedback for brain tumor therapy},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-025-03212-3}
}
EUVIMED